Maxim starts BioAffinity Technologies at Buy on CyPath Lung potential
PremiumThe FlyMaxim starts BioAffinity Technologies at Buy on CyPath Lung potential
2M ago
BioAffinity Technologies initiated with a Buy at Maxim
Premium
The Fly
BioAffinity Technologies initiated with a Buy at Maxim
2M ago
BioAffinity reports 217% revenue growth for CyPath Lung in Q2
Premium
The Fly
BioAffinity reports 217% revenue growth for CyPath Lung in Q2
2M ago
India regulators issue BioAffinity unit patent for targeted cancer treatment
PremiumThe FlyIndia regulators issue BioAffinity unit patent for targeted cancer treatment
8M ago
CMS posts payment info for BioAffinity’s CyPath Lung, effective January 2024
Premium
The Fly
CMS posts payment info for BioAffinity’s CyPath Lung, effective January 2024
10M ago
BioAffinity Technologies files $25M mixed securities shelf
Premium
The Fly
BioAffinity Technologies files $25M mixed securities shelf
10M ago
BioAffinity publishes results of trial for non-invasive diagnostic CyPath Lung
PremiumThe FlyBioAffinity publishes results of trial for non-invasive diagnostic CyPath Lung
2y ago
BioAffinity: USPTO gives notice to award patent protection to compounds
Premium
The Fly
BioAffinity: USPTO gives notice to award patent protection to compounds
2y ago
BioAffinity considering EU, China after U.S., CEO says
Premium
The Fly
BioAffinity considering EU, China after U.S., CEO says
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100